Viracta Therapeutics Stock Market Value
| VIRX Stock | USD 0.01 0.00 0.00% |
| Symbol | Viracta |
Viracta Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viracta Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viracta Therapeutics.
| 08/29/2025 |
| 11/27/2025 |
If you would invest 0.00 in Viracta Therapeutics on August 29, 2025 and sell it all today you would earn a total of 0.00 from holding Viracta Therapeutics or generate 0.0% return on investment in Viracta Therapeutics over 90 days. Viracta Therapeutics is related to or competes with Veolia Environnement, Marti Technologies, Axcelis Technologies, Amkor Technology, Tata Steel, and Tree Island. Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associa... More
Viracta Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viracta Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viracta Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Viracta Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viracta Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viracta Therapeutics' standard deviation. In reality, there are many statistical measures that can use Viracta Therapeutics historical prices to predict the future Viracta Therapeutics' volatility.Viracta Therapeutics Backtested Returns
We have found three technical indicators for Viracta Therapeutics, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Viracta Therapeutics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Viracta Therapeutics has perfect predictability. Overlapping area represents the amount of predictability between Viracta Therapeutics time series from 29th of August 2025 to 13th of October 2025 and 13th of October 2025 to 27th of November 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viracta Therapeutics price movement. The serial correlation of 1.0 indicates that 100.0% of current Viracta Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Viracta Therapeutics lagged returns against current returns
Autocorrelation, which is Viracta Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Viracta Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Viracta Therapeutics returns to help us make a trade decision. For example, suppose you find that Viracta Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Viracta Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Viracta Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Viracta Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Viracta Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Viracta Therapeutics Lagged Returns
When evaluating Viracta Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Viracta Therapeutics pink sheet have on its future price. Viracta Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Viracta Therapeutics autocorrelation shows the relationship between Viracta Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Viracta Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Viracta Pink Sheet Analysis
When running Viracta Therapeutics' price analysis, check to measure Viracta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viracta Therapeutics is operating at the current time. Most of Viracta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viracta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viracta Therapeutics' price. Additionally, you may evaluate how the addition of Viracta Therapeutics to your portfolios can decrease your overall portfolio volatility.